An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection

Obstetrics and Gynecology

Volumn 83, Issue 3, 1994, Pages 367-371

  Yancey, Michael K ^a   Duff, Patrick ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; PENICILLIN G;

ARTICLE; COST EFFECTIVENESS ANALYSIS; FETUS; HUMAN; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN INFECTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTOCOL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

CLINICAL PROTOCOLS; COMPARATIVE STUDY; COST-BENEFIT ANALYSIS; FEMALE; HUMAN; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PRENATAL CARE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0027982934     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Boyer KM. Maternal screening in prevention of neonatal infections: Current status and rationale for group B streptococcal screening. J Hosp Infect 1988;11(suppl A):328-33.
2. Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: A 6-year prospective study. J Pediatr 1987;110:31-6.
3. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: Results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7.
4. Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992;90:775-8.
5. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983;148:795-801.
6. Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gardner SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;241:1245-7.
7. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis 1983;148:810-6.
8. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
9. Allardice JG, Baskett TF, Seshia MMK, Bowman N, Malazdrewicz R. Perinatal group B streptococcal colonization and infection. Am J Obstet Gynecol 1982;142:617-20.
10. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983;148:802-9.
11. Yancey MK, Armer T, Clark P, Duff P. Assessment of rapid identification tests for genital carriage of group B streptococci. Obstet Gynecol 1992;80:1038-47.
12. Garland SM, Fliegner JR. Group B streptococcus (GBS) and neonatal infections: The case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol 1991;31:119-22.
13. Iams JD, O’Shaughnessy R. Antepartum versus intrapartum selective screening for maternal group B streptococcal colonization. Am J Obstet Gynecol 1982;143:153-6.
14. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: Intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73: 583-7.
15. Morales WJ, Lim D. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987;157:13-6.
16. American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy. ACOG technical bulletin no. 170. Washington, DC: American College of Obstetricians and Gynecologists, 1992.
17. Yancey MK, Clark P, Armer T, Duff P. Use of a DNA probe for the rapid detection of group B streptococci in obstetric patients. Obstet Gynecol 1993;81:635-40.
18. Strickland DM, Yeomans ER, Hankins GDV. Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol 1990;163:4-8.
19. Coleman RT, Sherer DM, Maniscalco WM. Prevention of neonatal group B streptococcal infections: Advances in maternal vaccine development. Obstet Gynecol 1992;80:301-9.